VPM4001

Thuốc Gốc

Biotech

VPM4001 is an allogeneic vaccine for treatment of prostate carcinoma. It consists of irradiated human LNCaP cells that have been genetically modified to permanently secrete interferon-γ and interleukin-2 (LNCaP/IL-2/IFN-γ). Interferon-γ enhances presentation of tumour antigens, whereas interleukin-2 stimulates T cells.

Chỉ Định : Investigated for use/treatment in prostate cancer.

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB05089

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading